Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir^® Phase II Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation

Todos Medical, Ltd. together with its 3CL biology-focused joint venture partner NLC Pharma, announced that all 31 patients enrolled to date in Tollovir® Phase II clinical trial in hospitalized COVID-19 patients completed study participation.